| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 19 | 2023 | 3552 | 2.310 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 9 | 2022 | 507 | 2.000 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 2488 | 0.900 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2022 | 854 | 0.810 |
Why?
|
| Radiation, Ionizing | 2 | 2019 | 187 | 0.770 |
Why?
|
| Fibroblasts | 2 | 2022 | 1682 | 0.590 |
Why?
|
| RNA, Untranslated | 7 | 2012 | 237 | 0.580 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 324 | 0.560 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 193 | 0.560 |
Why?
|
| Insulin-Like Growth Factor II | 5 | 2012 | 107 | 0.510 |
Why?
|
| Genomic Imprinting | 6 | 2012 | 194 | 0.490 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 589 | 0.490 |
Why?
|
| Mice | 26 | 2023 | 34495 | 0.450 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 3343 | 0.440 |
Why?
|
| Ubiquitin | 1 | 2014 | 344 | 0.430 |
Why?
|
| Longevity | 1 | 2013 | 154 | 0.420 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1411 | 0.410 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 2359 | 0.410 |
Why?
|
| DNA-Binding Proteins | 8 | 2006 | 4821 | 0.400 |
Why?
|
| Repressor Proteins | 6 | 2012 | 1664 | 0.400 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 589 | 0.400 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 242 | 0.390 |
Why?
|
| Protein Multimerization | 1 | 2011 | 240 | 0.370 |
Why?
|
| Models, Animal | 1 | 2012 | 664 | 0.360 |
Why?
|
| DNA Damage | 4 | 2014 | 1954 | 0.360 |
Why?
|
| Transcriptional Activation | 5 | 2023 | 1070 | 0.350 |
Why?
|
| Hematopoiesis | 1 | 2012 | 560 | 0.350 |
Why?
|
| Embryonic Development | 1 | 2011 | 306 | 0.340 |
Why?
|
| Gene Expression | 1 | 2017 | 3570 | 0.330 |
Why?
|
| Animals | 30 | 2023 | 59536 | 0.330 |
Why?
|
| Li-Fraumeni Syndrome | 2 | 2023 | 158 | 0.320 |
Why?
|
| Ribonuclease III | 2 | 2019 | 182 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 4053 | 0.300 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2019 | 255 | 0.300 |
Why?
|
| Mutation | 9 | 2022 | 15179 | 0.280 |
Why?
|
| Transcription Factors | 5 | 2014 | 5270 | 0.270 |
Why?
|
| Carcinogenesis | 4 | 2022 | 1026 | 0.260 |
Why?
|
| Cell Cycle Proteins | 3 | 2017 | 2045 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1498 | 0.250 |
Why?
|
| Protein Binding | 4 | 2022 | 3438 | 0.250 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 220 | 0.230 |
Why?
|
| Protein Stability | 2 | 2014 | 370 | 0.220 |
Why?
|
| Mice, Transgenic | 7 | 2018 | 4143 | 0.220 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 629 | 0.220 |
Why?
|
| Geminiviridae | 1 | 2001 | 1 | 0.210 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 44 | 0.200 |
Why?
|
| Fabaceae | 1 | 2001 | 26 | 0.200 |
Why?
|
| Osteosarcoma | 2 | 2022 | 929 | 0.200 |
Why?
|
| Organ Specificity | 1 | 2023 | 699 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 3101 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 126 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2019 | 11965 | 0.200 |
Why?
|
| Neoplasms, Experimental | 2 | 2018 | 750 | 0.190 |
Why?
|
| CCCTC-Binding Factor | 6 | 2012 | 33 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2018 | 2022 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2014 | 575 | 0.180 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 7222 | 0.170 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 82 | 0.170 |
Why?
|
| DNA Helicases | 1 | 2001 | 434 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 8873 | 0.170 |
Why?
|
| Models, Biological | 3 | 2019 | 3254 | 0.160 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 14551 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 171 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 164 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2019 | 5710 | 0.150 |
Why?
|
| Cloning, Molecular | 4 | 2006 | 1213 | 0.150 |
Why?
|
| Homozygote | 1 | 2018 | 717 | 0.140 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 221 | 0.140 |
Why?
|
| Mutation, Missense | 2 | 2018 | 1152 | 0.140 |
Why?
|
| Trans-Activators | 2 | 2006 | 1555 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 1242 | 0.140 |
Why?
|
| Doxorubicin | 2 | 2014 | 3005 | 0.140 |
Why?
|
| RNA, Long Noncoding | 7 | 2012 | 598 | 0.130 |
Why?
|
| Apoptosis | 4 | 2019 | 7591 | 0.130 |
Why?
|
| Lymphoma | 2 | 2017 | 1467 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2017 | 370 | 0.130 |
Why?
|
| ras Proteins | 1 | 2019 | 770 | 0.130 |
Why?
|
| Chromatin | 3 | 2012 | 942 | 0.130 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2014 | 13 | 0.120 |
Why?
|
| Genotype | 2 | 2014 | 4109 | 0.120 |
Why?
|
| Cycloheximide | 1 | 2014 | 97 | 0.120 |
Why?
|
| Leupeptins | 1 | 2014 | 68 | 0.120 |
Why?
|
| Dactinomycin | 1 | 2014 | 145 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2018 | 876 | 0.120 |
Why?
|
| Protein Denaturation | 1 | 2013 | 70 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 196 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 6942 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2014 | 235 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 1265 | 0.110 |
Why?
|
| Aging | 2 | 2018 | 1582 | 0.110 |
Why?
|
| Proteolysis | 1 | 2014 | 370 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 771 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 634 | 0.100 |
Why?
|
| Cesium Radioisotopes | 1 | 2011 | 39 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2011 | 406 | 0.100 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 575 | 0.100 |
Why?
|
| Point Mutation | 1 | 2014 | 769 | 0.100 |
Why?
|
| DNA Primers | 2 | 2011 | 1399 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 644 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2014 | 492 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 1960 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5637 | 0.090 |
Why?
|
| E2F5 Transcription Factor | 2 | 1999 | 8 | 0.090 |
Why?
|
| Transcription Factor DP1 | 2 | 1999 | 57 | 0.090 |
Why?
|
| E2F4 Transcription Factor | 2 | 1999 | 30 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 4549 | 0.080 |
Why?
|
| Learning | 1 | 2012 | 403 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 494 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2002 | 798 | 0.080 |
Why?
|
| DNA Methylation | 5 | 2012 | 2669 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 3639 | 0.080 |
Why?
|
| Humans | 18 | 2019 | 261506 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2022 | 2576 | 0.070 |
Why?
|
| Sarcoma | 1 | 2017 | 1725 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1823 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2012 | 1987 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2019 | 4804 | 0.070 |
Why?
|
| Chromosomes | 1 | 2006 | 244 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 5047 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2527 | 0.070 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2004 | 11 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 6089 | 0.060 |
Why?
|
| Alleles | 3 | 2018 | 2437 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2002 | 118 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 25 | 0.060 |
Why?
|
| Methylation | 1 | 2004 | 597 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2027 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2006 | 1399 | 0.050 |
Why?
|
| CpG Islands | 1 | 2004 | 633 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 57 | 0.050 |
Why?
|
| Binding Sites | 4 | 2012 | 2171 | 0.050 |
Why?
|
| Leukemia | 1 | 2010 | 1635 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2001 | 155 | 0.050 |
Why?
|
| Cell Death | 1 | 2023 | 671 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5061 | 0.050 |
Why?
|
| Female | 9 | 2018 | 141928 | 0.050 |
Why?
|
| Protein Folding | 1 | 2001 | 281 | 0.050 |
Why?
|
| Chloroplasts | 1 | 2000 | 14 | 0.050 |
Why?
|
| Male | 7 | 2018 | 123000 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 54 | 0.050 |
Why?
|
| E2F3 Transcription Factor | 1 | 1999 | 23 | 0.050 |
Why?
|
| E2F2 Transcription Factor | 1 | 1999 | 27 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 132 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 189 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 571 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 15193 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2002 | 837 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3981 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 1999 | 206 | 0.040 |
Why?
|
| Histone Chaperones | 1 | 2018 | 32 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2001 | 1258 | 0.040 |
Why?
|
| X-linked Nuclear Protein | 1 | 2018 | 56 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1998 | 73 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2018 | 122 | 0.040 |
Why?
|
| Base Sequence | 2 | 2001 | 4917 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 129 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 329 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 492 | 0.040 |
Why?
|
| Liver | 3 | 2014 | 2961 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 682 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 521 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 264 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 644 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 318 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 268 | 0.040 |
Why?
|
| Transfection | 2 | 2002 | 2944 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2000 | 549 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 15694 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 5395 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 844 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 2927 | 0.030 |
Why?
|
| Disease Progression | 2 | 2019 | 6682 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 602 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 848 | 0.030 |
Why?
|
| Histones | 2 | 2018 | 1466 | 0.030 |
Why?
|
| Transgenes | 1 | 2017 | 557 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1313 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 6150 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Response Elements | 1 | 2014 | 193 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1029 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 1203 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 3203 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 634 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 840 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1538 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2012 | 103 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2012 | 59 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 122 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2314 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 241 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 4233 | 0.030 |
Why?
|
| Aged | 1 | 2017 | 70117 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 162 | 0.020 |
Why?
|
| Plicamycin | 1 | 2010 | 30 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 528 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 518 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 86204 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 931 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 523 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2010 | 188 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 479 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 476 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 2508 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 1859 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 726 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 5112 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 744 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1408 | 0.020 |
Why?
|
| Actins | 1 | 2010 | 608 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 1163 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 1643 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 5539 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 987 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 3536 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2074 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2010 | 1090 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 279 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 2450 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 301 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 3154 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5178 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 2809 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 1338 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 2002 | 47 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 90 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 125 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 803 | 0.010 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 92 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 153 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 205 | 0.010 |
Why?
|
| Light | 1 | 2000 | 245 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2002 | 442 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 445 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 611 | 0.010 |
Why?
|
| Temperature | 1 | 2000 | 506 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 869 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 467 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 2002 | 545 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 889 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2002 | 834 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1537 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 21713 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 2693 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 7573 | 0.010 |
Why?
|